RT Journal Article
SR Electronic
T1 Response to: ‘Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson <em>et al</em>’ by Ebbo <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e27
OP e27
DO 10.1136/annrheumdis-2020-217029
VO 81
IS 2
A1 Simpson, Rachel S
A1 Lee, Jason K
YR 2022
UL http://ard.bmj.com/content/81/2/e27.abstract
AB